Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.

Publication

Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.

Journal Paper/Review - Mar 4, 2023

Tancredi Stefano, Chiolero Arnaud, Wagner Cornelia, Haller Moa Lina, Chocano-Bedoya Patricia O, Ortega Natalia, Rodondi Nicolas, Kaufmann Laurent, Lorthe Elsa, Baysson Hélène, Stringhini Silvia, Michel Gisela, Luedi Chantal, Harju Erika, Frank Irène, Imboden Medea, Witzig Melissa, Keidel Dirk, Probst-Hensch Nicole M, Amati Rebecca, Albanese Emiliano, Corna Laurie, Crivelli Luca, Vincentini Julia, Nusslé Semira Gonseth, Bochud Murielle, d'Acremont Valérie, Kohler Philipp, Kahlert Christian, Cusini Alexia, Frei Anja, Puhan Milo Alan, Geigges Marco, Kaufmann Marco, Fehr Jan S, Cullati Stéphane, Corona Immunitas Research Group

Citation

Tancredi S, Chiolero A, Wagner C, Haller M, Chocano-Bedoya P, Ortega N, Rodondi N, Kaufmann L, Lorthe E, Baysson H, Stringhini S, Michel G, Luedi C, Harju E, Frank I, Imboden M, Witzig M, Keidel D, Probst-Hensch N, Amati R, Albanese E, Corna L, Crivelli L, Vincentini J, Nusslé S, Bochud M, d'Acremont V, Kohler P, Kahlert C, Cusini A, Frei A, Puhan M, Geigges M, Kaufmann M, Fehr J, Cullati S, Corona Immunitas Research Group. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study. Infection 2023; 51:1453-1465.

Type

Journal Paper/Review (English)

Journal

Infection 2023; 51

Publication Date

Mar 4, 2023

Issn Electronic

1439-0973

Pages

1453-1465

Brief description/objective

We aimed to assess the seroprevalence trends of SARS-CoV-2 antibodies in several Swiss cantons between May 2020 and September 2021 and investigate risk factors for seropositivity and their changes over time.